These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17581441)

  • 41. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 42. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
    Schachar RJ; Tannock R; Cunningham C; Corkum PV
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):754-63. PubMed ID: 9183129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 44. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 46. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
    Ghanizadeh A
    Acta Ophthalmol; 2010 Mar; 88(2):e56. PubMed ID: 19508459
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving decision making in the treatment of ADHD.
    Vitiello B
    Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
    [No Abstract]   [Full Text] [Related]  

  • 48. The answerable question and a hierarchy of evidence.
    Hamilton J
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
    [No Abstract]   [Full Text] [Related]  

  • 49. A dose-ranging study of a methylphenidate transdermal system in children with ADHD.
    Pelham WE; Manos MJ; Ezzell CE; Tresco KE; Gnagy EM; Hoffman MT; Onyango AN; Fabiano GA; Lopez-Williams A; Wymbs BT; Caserta D; Chronis AM; Burrows-Maclean L; Morse G
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 51. QuilliChew ER--extended-release chewable methylphenidate tablets.
    Med Lett Drugs Ther; 2016 May; 58(1495):68-9. PubMed ID: 27192619
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.
    Pearson DA; Lane DM; Santos CW; Casat CD; Jerger SW; Loveland KA; Faria LP; Mansour R; Henderson JA; Payne CD; Roache JD; Lachar D; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):686-98. PubMed ID: 15167085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulant use and trichotillomania.
    Martin A; Scahill L; Vitulano L; King RA
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):349-50. PubMed ID: 9549952
    [No Abstract]   [Full Text] [Related]  

  • 54. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aptensio XR--another long-acting methylphenidate.
    Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
    [No Abstract]   [Full Text] [Related]  

  • 56. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real impairments, real treatments.
    Kramer PD
    Am J Bioeth; 2005; 5(3):62-3; discussion W10-2. PubMed ID: 16006347
    [No Abstract]   [Full Text] [Related]  

  • 58. Priapism associated with methylphenidate: a case report.
    Cakin-Memik N; Yildiz O; Sişmanlar SG; Karakaya I; Ağaoğlu B
    Turk J Pediatr; 2010; 52(4):430-4. PubMed ID: 21043394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.
    Coskun M; Zoroglu S
    J Clin Psychopharmacol; 2008 Dec; 28(6):723-5. PubMed ID: 19011457
    [No Abstract]   [Full Text] [Related]  

  • 60. Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder.
    Monteerarat Y; Pariwatcharakul P
    J Clin Psychopharmacol; 2019; 39(2):178-179. PubMed ID: 30811376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.